Solana

Solana Inventory

The Inventory of Solana (HSDT) as of Nov 17, 2026 is 1.12 M USD. In the previous year, Inventory was 1.09 M USD — a change of 2.75% (higher).

Inventory

1.12 MUSD

YoY

2.75%

Last updated:

Inventory of Solana is 2025 1.12 M USD. Inventory of Solana was 2024 1.09 M USD. It decreases by 2.75% higher compared to the previous year.

The Solana Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
392,000.00 USD
Jan 1, 2019
598,000.00 USD
Jan 1, 2020
389,000.00 USD
Jan 1, 2021
476,000.00 USD
Jan 1, 2022
589,000.00 USD
Jan 1, 2023
457,000.00 USD
Jan 1, 2024
1.09 M USD
Jan 1, 2025
1.12 M USD
The Solana Inventory history
YEARInventoryYoY
1.12 MUSD+2.75%
1.09 MUSD+138.73%
457,000.00USD-22.41%
589,000.00USD+23.74%
476,000.00USD+22.37%
389,000.00USD-34.95%
598,000.00USD+52.55%
392,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Solana Stock analysis

What does Solana do? Helius Medical Technologies develops and markets the PoNS device, a portable neuromodulation stimulator for neurological wellness. The company focuses on non-invasive platform technologies that enhance the brain's healing ability. The PoNS device is authorized as a class II medical device in Canada for short-term treatment of chronic balance deficits caused by mild-to-moderate traumatic brain injury, used alongside physical therapy. It delivers non-invasive neurostimulation to the tongue to induce neuromodulation. Helius Medical Technologies targets healthcare providers and rehabilitation centers that treat patients with traumatic brain injury. The company's product is designed for use in clinical settings under professional guidance, specifically for patients requiring short-term balance deficit therapy. The PoNS device is positioned as a complementary treatment within physical therapy protocols for neurological rehabilitation. The firm's revenue model is based on the sale of the PoNS device to healthcare institutions and rehabilitation facilities. These institutions purchase the device for use in their treatment programs, leveraging its non-invasive neurostimulation technology to address balance deficits in patients with mild-to-moderate traumatic brain injury. The company's focus on neurological wellness through non-invasive solutions drives its commercial strategy. Solana is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Solana stock

Inventory of Solana is 1.12 M USD in 2025.

Inventory of Solana changed from 1.09 M USD to 1.12 M USD, representing a 2.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Solana since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Solana historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Solana

All Key Metrics — Solana